Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Adeia
ADEA
$3.11B
| $406K | ﹤0.01% |
45,814
+24,367
| +114% | +$244K |
|
2127
Liberty Latin America Class C
LILAK
$1.68B
| $405K | ﹤0.01% |
53,952
+20,638
| +62% | +$164K |
|
2128
Astec Industries
ASTE
$983M
| $405K | ﹤0.01% |
+9,827
| New | +$415K |
|
2129
Claros Mortgage Trust
CMTG
$265M
| $404K | ﹤0.01% |
34,756
+18,329
| +112% | +$263K |
|
2130
Mesa Laboratories
MLAB
$618M
| $404K | ﹤0.01% |
+2,314
| New | +$415K |
|
2131
Shenandoah Telecom
SHEN
$728M
| $403K | ﹤0.01% |
+21,207
| New | +$396K |
|
|
ATRI
2132
DELISTED
Atrion Corp
ATRI
| $403K | ﹤0.01% |
+637
| New | +$406K |
|
|
FLNA
2133
Filana Therapeutics
FLNA
$45.8M
| $402K | ﹤0.01% |
16,690
+9,156
| +122% | +$254K |
|
2134
IMAX
IMAX
$2.77B
| $402K | ﹤0.01% |
+20,968
| New | +$361K |
|
2135
Ecovyst
ECVT
$1.1B
| $402K | ﹤0.01% |
36,398
+18,814
| +107% | +$195K |
|
2136
Fluence Energy
FLNC
$2.44B
| $402K | ﹤0.01% |
19,854
-31,684
| -61% | -$629K |
|
|
RNAM
2137
DELISTED
Avidity Biosciences
RNAM
| $401K | ﹤0.01% |
+26,156
| New | +$575K |
|
|
PDM
2138
Piedmont Realty Trust
PDM
$1.19B
| $399K | ﹤0.01% |
54,690
+29,520
| +117% | +$271K |
|
|
BBBY
2139
Bed Bath & Beyond
BBBY
$412M
| $398K | ﹤0.01% |
+21,599
| New | +$403K |
|
2140
Protagonist Therapeutics
PTGX
$9.85B
| $397K | ﹤0.01% |
+17,250
| New | +$290K |
|
|
STER
2141
DELISTED
Sterling Check Corp. Common Stock
STER
| $397K | ﹤0.01% |
35,617
+19,929
| +127% | +$262K |
|
2142
German American Bancorp
GABC
$1.91B
| $396K | ﹤0.01% |
+11,874
| New | +$442K |
|
2143
Unitil
UTL
$985M
| $396K | ﹤0.01% |
+6,959
| New | +$372K |
|
2144
QCR Holdings
QCRH
$1.73B
| $395K | ﹤0.01% |
8,994
+4,253
| +90% | +$212K |
|
|
ACCD
2145
DELISTED
Accolade Inc
ACCD
| $395K | ﹤0.01% |
27,455
+14,653
| +114% | +$166K |
|
2146
Usana Health Sciences
USNA
$260M
| $394K | ﹤0.01% |
+6,272
| New | +$374K |
|
|
SPTN
2147
DELISTED
SpartanNash
SPTN
| $394K | ﹤0.01% |
15,902
+8,623
| +118% | +$248K |
|
|
DCH
2148
Dauch Corp
DCH
$1.6B
| $394K | ﹤0.01% |
50,482
+27,490
| +120% | +$236K |
|
|
TE
2149
T1 Energy
TE
$1.43B
| $393K | ﹤0.01% |
44,271
+25,371
| +134% | +$221K |
|
|
SLCA
2150
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $393K | ﹤0.01% |
32,954
+17,869
| +118% | +$213K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.